drugset

drugset / Trial / NCT01225939

A Study Conducted Over 3 Periods to Look at the Drug in the Body

NCT01225939 ↗

Phase 1 Completed 18 enrolled AstraZeneca

RandomizedCrossoverOpen-labelTreatment

Summary

A study conducted over 3 periods to look at the drug in the body.

Timeline

Start: 2010-11
Primary completion: 2010-12
Completion: 2010-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZD8329	Unknown	—	Oral

Indications